Rayca Precision is an AI-native operating system for drug development, built to break the silos that pharma R&D runs on, where the data already scattered across a pipeline is reconnected and put back to work, and where the walls between discovery and development come down. Held in one place and compounding across programs, that becomes a collective intelligence for how the world makes medicine. Faster to the clinic. Cheaper per cure. More diseases in reach. Drug development has no memory, and that is its most expensive flaw. Rayca pulls developability, delivery, and formulation forward into design. Our agentic engine carries a program from target to candidate, pairs generative design with physics-based simulation, models targets as conformational ensembles, and surfaces the cryptic and allosteric pockets that make hard targets tractable.
| Website | https://rayca.ai/ |
| Employees | 13 (5 on RocketReach) |
| Founded | 2022 |
| Industry | Biotechnology Research |
| Competitors | Nexgen Precision, Precision Analytics Inc, Arcadian Services of Colorado, Intellimed Solutions, Dynamic Biosystems, A&I HEALTH SOLUTIONS LLC, MedTech Analytics, LLC, Smartmed Technologies, HealthSphere ®, Accurate Health Solutions (view competitors) |
Looking for a particular Rayca Precision employee's phone or email?
Pouya Behrouzi is the CEO and Co-Founder of Rayca Precision.
5 people are employed at Rayca Precision.